Skip Navigation


The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients

Home » Advanced Search

Search Results for iron

Perform Another (Advanced) Search

Related Words: iron, chain, chains, iron

470 Results within Entire Site

Limit results to show:

1.  Study Posting (5276) Trial #148469, Uterine Fibroids, Houston, TX
...to one of the three treatment groups. Subjects will receive 325 mg (65 mg elemental iron) iron supplements to be taken twice daily during study drug treatment. The study duration is approximately ...
View Page

2.  Study Posting (5276) Trial #148467, Uterine Fibroids, Houston, TX
...to one of the three treatment groups. Subjects will receive 325 mg (65 mg elemental iron) iron supplements to be taken twice daily during study drug treatment. The study duration is approximately ...
View Page

3.  Study Posting (5276) Trial #148465, Uterine Fibroids, Columbia, SC
...to one of the three treatment groups. Subjects will receive 325 mg (65 mg elemental iron) iron supplements to be taken twice daily during study drug treatment. The study duration is approximately ...
View Page

4.  Study Posting (5276) Trial #148464, Uterine Fibroids, Moorestown, NJ
...to one of the three treatment groups. Subjects will receive 325 mg (65 mg elemental iron) iron supplements to be taken twice daily during study drug treatment. The study duration is approximately ...
View Page

5.  Study Posting (5276) Trial #148461, Uterine Fibroids, Tampa, FL
...to one of the three treatment groups. Subjects will receive 325 mg (65 mg elemental iron) iron supplements to be taken twice daily during study drug treatment. The study duration is approximately ...
View Page

6.  Study Posting (5276) Trial #148462, Uterine Fibroids, Leesburg, FL
...to one of the three treatment groups. Subjects will receive 325 mg (65 mg elemental iron) iron supplements to be taken twice daily during study drug treatment. The study duration is approximately ...
View Page

7.  Study Posting (5276) Trial #148460, Uterine Fibroids, Denver, CO
...to one of the three treatment groups. Subjects will receive 325 mg (65 mg elemental iron) iron supplements to be taken twice daily during study drug treatment. The study duration is approximately ...
View Page

8.  Study Posting (5276) Trial #148459, Uterine Fibroids, Phoenix, AZ
...to one of the three treatment groups. Subjects will receive 325 mg (65 mg elemental iron) iron supplements to be taken twice daily during study drug treatment. The study duration is approximately ...
View Page

9.  Study Posting (5276) Trial #148458, Uterine Fibroids, Birmingham, AL
...to one of the three treatment groups. Subjects will receive 325 mg (65 mg elemental iron) iron supplements to be taken twice daily during study drug treatment. The study duration is approximately ...
View Page

10.  Study Posting (5276) Trial #148468, Uterine Fibroids, San Antonio, TX
...to one of the three treatment groups. Subjects will receive 325 mg (65 mg elemental iron) iron supplements to be taken twice daily during study drug treatment. The study duration is approximately ...
View Page

11.  Study Posting (5276) Trial #148470, Uterine Fibroids, San Antonio, TX
...to one of the three treatment groups. Subjects will receive 325 mg (65 mg elemental iron) iron supplements to be taken twice daily during study drug treatment. The study duration is approximately ...
View Page

12.  Study Posting (5276) Trial #148466, Uterine Fibroids, Corpus Christi, TX
...to one of the three treatment groups. Subjects will receive 325 mg (65 mg elemental iron) iron supplements to be taken twice daily during study drug treatment. The study duration is approximately ...
View Page

13.  Study Posting (5276) Trial #148463, Uterine Fibroids, Boynton Beach, FL
...to one of the three treatment groups. Subjects will receive 325 mg (65 mg elemental iron) iron supplements to be taken twice daily during study drug treatment. The study duration is approximately ...
View Page

14.  Study Posting (5277) Trial #148473, Anemia, Mexico City, Federal District, Mexico
...to one of the three treatment groups. Subjects will receive 325 mg (65 mg elemental iron) iron supplements to be taken twice daily during study drug treatment. The study duration is approximately ...
View Page

15.  Newly Approved Drug Therapies (534) Ferrlecit, R&D Laboratories,
...Treatment Area: Anemia General Information Ferrlecit® is used to replete the total body content of iron. Iron is critical for normal hemoglobin synthesis to maintain oxygen transport. Additionally, iron is necessary for ...
View Page

16.  Study Posting (5277) Trial #148475, Anemia, San Miguel de Allende, Gto, Mexico
...to one of the three treatment groups. Subjects will receive 325 mg (65 mg elemental iron) iron supplements to be taken twice daily during study drug treatment. The study duration is approximately ...
View Page

17.  Newly Approved Drug Therapies (653) Venofer (iron sucrose injection), Luitpold Pharmaceuticals,
...Newly Approved Drug Therapies (653) Venofer (iron sucrose injection), Luitpold Pharmaceuticals, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Venofer (iron sucrose injection) Company: Luitpold Pharmaceuticals Approval Status: Approved November 2000 Treatment Area: Iron deficiency anemia ...
View Page

18.  Study Posting (77) Trial #153219, Iron Overload (Hemachromatosis), New Hyde Park, NY
...Study Posting (77) Trial #153219, Iron Overload (Hemachromatosis), New Hyde Park, NY Trial Information Iron overload - Minors/Adults Subjects who have too much iron in the body, also called iron ...
View Page

19.  CenterWatch: Clinical Trials in Category (403) Iron Overload (Hemachromatosis)
...CenterWatch: Clinical Trials in Category (403) Iron Overload (Hemachromatosis) Iron Overload (Hemachromatosis) State • New York New York New Hyde Park : Biomedical Research Alliance of New ...
View Page

20.  Newly Approved Drug Therapies (1035) Feraheme (ferumoxytol), AMAG,
...conference presentations. Drug Name: Feraheme (ferumoxytol) Company: AMAG Approval Status: Approved June 2009 Treatment Area: iron deficiency anemia associated with chronic kidney disease General Information Feraheme is a superparamagnetic iron oxide nanoparticle coated with a low molecular weight semi-synthetic carbohydrate. It helps to isolate ...
View Page


Jobson Medical Information

Copyright © 2008 Jobson Medical Information LLC.


Designed by Piehead Productions LLC.